Top section
Top section
◆ Fast money reverses out of SSA bond market ◆ CLO managers face risky ramp startegy ◆ Corporate hybrid bond market runs hot despite volatility
◆ French pharma prints along liquid parts of the curve ◆ Two shorter tranches land flat to fair value ◆ Danaher showed demand for high rated issuers earlier in the week
◆ Safer credits prove popular in uncertain market ◆ Alliander sheds orders as it punches through fair value ◆ Argan ends near five year euro absence
Data
More articles
More articles
More articles
-
Tightly trading bonds look ripe to gap wider as conditions expected to deteriorate -
Investors forced to accept deals priced close to secondary curve as supply dwindles
-
Borrower signs 12 year deal as European high yield spreads tipped to soar
-
Even lowest rated names only pay up a handful of basis points
-
New names welcomed ahead of next week's Fed meeting
-
UBS has kicked off its first round of job cuts ahead of unveiling the new leadership of its corporate finance business
Sub-sections
